1801 Quintard Avenue, Anniston, AL 36201 | Phone: (256) 403-0500 | Fax: (866) 912-6586 | Mon-Fri 9:00am - 7:00pm | Sat 9:00am - 6:00pm | Sun 12:00pm - 6:00pm
¡Pregúntenos sobre nuestro servicio de notificaciones por texto y correo electrónico ¡Pregúntenos sobre nuestro servicio de notificaciones por texto y correo electrónico
Queremos a su familia feliz y en buena salud.<br> ¡Llámenos hoy para hacer cita para sus vacunas! Queremos a su familia feliz y en buena salud.
¡Llámenos hoy para hacer cita para sus vacunas!
Rápido y conveniente auto servicio Rápido y conveniente auto servicio Obtener dirección
¿Busca equipos médicos? <br><br>Tenemos una línea completa de equipos medicos. ¿Busca equipos médicos?

Tenemos una línea completa de equipos medicos.
Manténgase en buena salud <br> ¡Estamos para servirles! Manténgase en buena salud
¡Estamos para servirles!
Recursos del Paciente
Download iPhone App Download Google Play App Text Me A Link
Últimas Noticias y videos.

Mantenerse informado(a) promueve la buena salud. Manténgase al día con las últimas noticias médicas encontradas aquí.

16 Jun

Rheumatoid Arthritis On The Rise Worldwide

A new study finds rising rates of rheumatoid arthritis worldwide between 1990 and 2021. And researchers say the autoimmune disease is hitting more younger adults.

13 Jun

Prenatal PFAS Exposure Linked to High Blood Pressure in Teens

Prenatal exposure to PFAS or “forever chemicals” is associated with an increased risk for high blood pressure later in childhood, especially among boys, according to researchers.

12 Jun

Biking in Mid-Life May Lower the Risk for Dementia and Alzheimer’s Disease

A new study finds active transportation modes like biking may help lower the risk of dementia and protect a part of the brain linked to memory.

Psychedelics Can Help Cancer Patients Battling Depression

Psychedelics Can Help Cancer Patients Battling Depression

TUESDAY, June 17, 2025 (HealthDay News) — Magic mushrooms might be key to quelling depression among people battling cancer.

A single dose of psilocybin provided sustained reductions in depression and anxiety among cancer patients diagnosed with major depression, according to small-scale study published June 16 in the journal Canc...

Dementia Caregivers Themselves At Higher Risk For Brain Aging

Dementia Caregivers Themselves At Higher Risk For Brain Aging

TUESDAY, June 17, 2025 (HealthDay News) — People caring for people with dementia might face future risk with their own brain aging due to lifestyle factors, a new study says.

Nearly 3 in 5 dementia caregivers (59%) have at least one risk factor that increases their own chances of developing dementia over time, according to a June 12 ...

Blood Pressure Diet Helps Type 2 Diabetics

Blood Pressure Diet Helps Type 2 Diabetics

TUESDAY, June 17, 2025 (HealthDay News) — A diet meant to lower blood pressure also can be effective in treating type 2 diabetes after a few tweaks, a new clinical trial indicates.

The DASH (Dietary Approaches to Stop Hypertension) diet effectively treated high blood pressure among type 2 diabetics, researchers reported recently in <...

Electroshock Therapy Appears To Reduce Suicide Risk Among People With Depression

Electroshock Therapy Appears To Reduce Suicide Risk Among People With Depression

TUESDAY, June 17, 2025 (HealthDay News) — People with severe depression who receive electroshock therapy are significantly less likely to commit suicide, a new evidence review says.

Electroconvulsive therapy (ECT) lowered the risk of death by suicide 34% among patients with severe depression, according to findings published June 13 i...

Digital Tool Potentially Predicts Childhood Asthma

Digital Tool Potentially Predicts Childhood Asthma

TUESDAY, June 17, 2025 (HealthDay News) — A new digital tool can flag kids who are at risk for developing childhood asthma, researchers report.

The tool scans electronic health data records and calculates an asthma risk score for children, according to results published recently in eClinical Medicine.

It relies on info...

Texas Invests $50M in Psychedelic Drug Research to Treat Addiction

Texas Invests $50M in Psychedelic Drug Research to Treat Addiction

MONDAY, June 16, 2025 (HealthDay News) — Texas has moved to fund research into ibogaine, a psychedelic drug that may help treat addiction, depression and brain injuries.

Gov. Greg Abbott signed a bill last week approving $50 million in state funds for ibogaine research, The New York Times reported.

The goal is to suppo...

HealthDay
El servicio de noticias de salud es un servicio para los usuarios de la página web de Martin's Pharmacy #203 gracias a HealthDay. Martin's Pharmacy #203 ni sus empleados, agentes, o contratistas, revisan, controlan, o toman responsabilidad por el contenido de los artículos. Por favor busque consejo médico directamente de un farmacéutico o de su médico principal.
Derechos de autor © 2025 HealthDay Reservados todos los derechos.

Nuestras afiliados

American Associated Pharmacies
Cardinal Health
Leader Pharmacies